Global Radioactive Medical Isotopes Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10245424

Publication Date:

November 1, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Radioactive Medical Isotopes market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淩adioactive Medical Isotopes Industry Forecast鈥� looks at past sales and reviews total world Radioactive Medical Isotopes sales in 2022, providing a comprehensive analysis by region and market sector of projected Radioactive Medical Isotopes sales for 2023 through 2029. With Radioactive Medical Isotopes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioactive Medical Isotopes industry.
This Insight Report provides a comprehensive analysis of the global Radioactive Medical Isotopes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radioactive Medical Isotopes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Radioactive Medical Isotopes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioactive Medical Isotopes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioactive Medical Isotopes.
United States market for Radioactive Medical Isotopes is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Radioactive Medical Isotopes is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Radioactive Medical Isotopes is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Radioactive Medical Isotopes players cover NRG, NTP Radioisotopes, JSC Isotope, ANSTO, China National Nuclear Corporation (CNNC), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Radioactive Medical Isotopes market by product type, application, key players and key regions and countries.
Segmentation by Type:
Carbon-14
Technetium-99m
Iodine-131
Iodine-125
Others
Segmentation by Application:
Diagnosis
Treatment
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Carbon-14
Technetium-99m
Iodine-131
Iodine-125
Others
Segmentation by Application:
Diagnosis
Treatment
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
China National Nuclear Corporation (CNNC)
IRE ELIT
Nordion
Polatom

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Radioactive Medical Isotopes Market Size 2019-2030
2.1.2 Radioactive Medical Isotopes Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Radioactive Medical Isotopes by Country/Region, 2019, 2023 & 2030
2.2 Radioactive Medical Isotopes Segment by Type
2.2.1 Carbon-14
2.2.2 Technetium-99m
2.2.3 Iodine-131
2.2.4 Iodine-125
2.2.5 Others
2.3 Radioactive Medical Isotopes Market Size by Type
2.3.1 Radioactive Medical Isotopes Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Radioactive Medical Isotopes Market Size Market Share by Type (2019-2024)
2.4 Radioactive Medical Isotopes Segment by Application
2.4.1 Diagnosis
2.4.2 Treatment
2.4.3 Others
2.5 Radioactive Medical Isotopes Market Size by Application
2.5.1 Radioactive Medical Isotopes Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Radioactive Medical Isotopes Market Size Market Share by Application (2019-2024)
3 Radioactive Medical Isotopes Market Size by Player
3.1 Radioactive Medical Isotopes Market Size Market Share by Player
3.1.1 Global Radioactive Medical Isotopes Revenue by Player (2019-2024)
3.1.2 Global Radioactive Medical Isotopes Revenue Market Share by Player (2019-2024)
3.2 Global Radioactive Medical Isotopes Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Radioactive Medical Isotopes by Region
4.1 Radioactive Medical Isotopes Market Size by Region (2019-2024)
4.2 Global Radioactive Medical Isotopes Annual Revenue by Country/Region (2019-2024)
4.3 Americas Radioactive Medical Isotopes Market Size Growth (2019-2024)
4.4 APAC Radioactive Medical Isotopes Market Size Growth (2019-2024)
4.5 Europe Radioactive Medical Isotopes Market Size Growth (2019-2024)
4.6 Middle East & Africa Radioactive Medical Isotopes Market Size Growth (2019-2024)
5 Americas
5.1 Americas Radioactive Medical Isotopes Market Size by Country (2019-2024)
5.2 Americas Radioactive Medical Isotopes Market Size by Type (2019-2024)
5.3 Americas Radioactive Medical Isotopes Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radioactive Medical Isotopes Market Size by Region (2019-2024)
6.2 APAC Radioactive Medical Isotopes Market Size by Type (2019-2024)
6.3 APAC Radioactive Medical Isotopes Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Radioactive Medical Isotopes Market Size by Country (2019-2024)
7.2 Europe Radioactive Medical Isotopes Market Size by Type (2019-2024)
7.3 Europe Radioactive Medical Isotopes Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Radioactive Medical Isotopes by Region (2019-2024)
8.2 Middle East & Africa Radioactive Medical Isotopes Market Size by Type (2019-2024)
8.3 Middle East & Africa Radioactive Medical Isotopes Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Radioactive Medical Isotopes Market Forecast
10.1 Global Radioactive Medical Isotopes Forecast by Region (2025-2030)
10.1.1 Global Radioactive Medical Isotopes Forecast by Region (2025-2030)
10.1.2 Americas Radioactive Medical Isotopes Forecast
10.1.3 APAC Radioactive Medical Isotopes Forecast
10.1.4 Europe Radioactive Medical Isotopes Forecast
10.1.5 Middle East & Africa Radioactive Medical Isotopes Forecast
10.2 Americas Radioactive Medical Isotopes Forecast by Country (2025-2030)
10.2.1 United States Market Radioactive Medical Isotopes Forecast
10.2.2 Canada Market Radioactive Medical Isotopes Forecast
10.2.3 Mexico Market Radioactive Medical Isotopes Forecast
10.2.4 Brazil Market Radioactive Medical Isotopes Forecast
10.3 APAC Radioactive Medical Isotopes Forecast by Region (2025-2030)
10.3.1 China Radioactive Medical Isotopes Market Forecast
10.3.2 Japan Market Radioactive Medical Isotopes Forecast
10.3.3 Korea Market Radioactive Medical Isotopes Forecast
10.3.4 Southeast Asia Market Radioactive Medical Isotopes Forecast
10.3.5 India Market Radioactive Medical Isotopes Forecast
10.3.6 Australia Market Radioactive Medical Isotopes Forecast
10.4 Europe Radioactive Medical Isotopes Forecast by Country (2025-2030)
10.4.1 Germany Market Radioactive Medical Isotopes Forecast
10.4.2 France Market Radioactive Medical Isotopes Forecast
10.4.3 UK Market Radioactive Medical Isotopes Forecast
10.4.4 Italy Market Radioactive Medical Isotopes Forecast
10.4.5 Russia Market Radioactive Medical Isotopes Forecast
10.5 Middle East & Africa Radioactive Medical Isotopes Forecast by Region (2025-2030)
10.5.1 Egypt Market Radioactive Medical Isotopes Forecast
10.5.2 South Africa Market Radioactive Medical Isotopes Forecast
10.5.3 Israel Market Radioactive Medical Isotopes Forecast
10.5.4 Turkey Market Radioactive Medical Isotopes Forecast
10.6 Global Radioactive Medical Isotopes Forecast by Type (2025-2030)
10.7 Global Radioactive Medical Isotopes Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Radioactive Medical Isotopes Forecast
11 Key Players Analysis
11.1 NRG
11.1.1 NRG Company Information
11.1.2 NRG Radioactive Medical Isotopes Product Offered
11.1.3 NRG Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 NRG Main Business Overview
11.1.5 NRG Latest Developments
11.2 NTP Radioisotopes
11.2.1 NTP Radioisotopes Company Information
11.2.2 NTP Radioisotopes Radioactive Medical Isotopes Product Offered
11.2.3 NTP Radioisotopes Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 NTP Radioisotopes Main Business Overview
11.2.5 NTP Radioisotopes Latest Developments
11.3 JSC Isotope
11.3.1 JSC Isotope Company Information
11.3.2 JSC Isotope Radioactive Medical Isotopes Product Offered
11.3.3 JSC Isotope Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 JSC Isotope Main Business Overview
11.3.5 JSC Isotope Latest Developments
11.4 ANSTO
11.4.1 ANSTO Company Information
11.4.2 ANSTO Radioactive Medical Isotopes Product Offered
11.4.3 ANSTO Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 ANSTO Main Business Overview
11.4.5 ANSTO Latest Developments
11.5 China National Nuclear Corporation (CNNC)
11.5.1 China National Nuclear Corporation (CNNC) Company Information
11.5.2 China National Nuclear Corporation (CNNC) Radioactive Medical Isotopes Product Offered
11.5.3 China National Nuclear Corporation (CNNC) Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 China National Nuclear Corporation (CNNC) Main Business Overview
11.5.5 China National Nuclear Corporation (CNNC) Latest Developments
11.6 IRE ELIT
11.6.1 IRE ELIT Company Information
11.6.2 IRE ELIT Radioactive Medical Isotopes Product Offered
11.6.3 IRE ELIT Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 IRE ELIT Main Business Overview
11.6.5 IRE ELIT Latest Developments
11.7 Nordion
11.7.1 Nordion Company Information
11.7.2 Nordion Radioactive Medical Isotopes Product Offered
11.7.3 Nordion Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Nordion Main Business Overview
11.7.5 Nordion Latest Developments
11.8 Polatom
11.8.1 Polatom Company Information
11.8.2 Polatom Radioactive Medical Isotopes Product Offered
11.8.3 Polatom Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Polatom Main Business Overview
11.8.5 Polatom Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂